To tack­le soar­ing pre­scrip­tion drug costs, Cana­da cre­ates new agency to ne­go­ti­ate prices; DMC clears phI­II test­ing of Cy­to­ki­net­ic­s' Am­gen-part­nered heart drug

→ Amer­i­cans aren’t the on­ly ones cry­ing hoarse about soar­ing pre­scrip­tion drug prices. In its 2019 bud­get un­veiled on Tues­day, neigh­bor­ing Cana­da has de­cid­ed to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER